Prostaglandin PGE2 Receptor EP4 Regulates Microglial Phagocytosis and Increases Susceptibility to Diet-Induced Obesity
Diabetes · 2023
DOI: 10.2337/db21-1072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, 2023. Verfasst von Anzela Niraula und 6 weiteren Autor:innen. Beteiligte Einrichtung: UW Medicine Diabetes Institute, University of Washington, Seattle, WA. Hauptthemen laut MEDLINE: Dinoprostone, Microglia, Obesity. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, American Heart Association.
Abstract (Originalsprache)
In rodents, susceptibility to diet-induced obesity requires microglial activation, but the molecular components of this pathway remain incompletely defined. Prostaglandin PGE2 levels increase in the mediobasal hypothalamus during high-fat-diet (HFD) feeding, and the PGE2 receptor EP4 regulates microglial activation state and phagocytic activity, suggesting a potential role for microglial EP4 signaling in obesity pathogenesis. To test the role of microglial EP4 in energy balance regulation, we analyzed the metabolic phenotype in a microglia-specific EP4 knockout (MG-EP4 KO) mouse model. Microglial EP4 deletion markedly reduced weight gain and food intake in response to HFD feeding. Corresponding with this lean phenotype, insulin sensitivity was also improved in HFD-fed MG-EP4 KO mice, though glucose tolerance remained surprisingly unaffected. Mechanistically, EP4-deficient microglia showed an attenuated phagocytic state marked by reduced CD68 expression and fewer contacts with pro-opiomelanocortin (POMC) neuron processes. These cellular changes observed in the MG-EP4 KO mice corresponded with an increased density of POMC neurites extending into the paraventricular nucleus (PVN). These findings reveal that microglial EP4 signaling promotes body weight gain and insulin resistance during HFD feeding. Furthermore, the data suggest that curbing microglial phagocytic function may preserve POMC cytoarchitecture and PVN input to limit overconsumption during diet-induced obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- UW Medicine Diabetes Institute, University of Washington, Seattle, WA.
- Department of Medicine, University of Washington, Seattle, WA.
ORCID-Profile: Joshua P Thaler
Förderung
- NIDDK NIH HHS
- NHLBI NIH HHS
- American Heart Association
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Niraula, A., Fasnacht, R. D., Ness, K. M., Frey, J. M., Cuschieri, S. A., Dorfman, M. D., & Thaler, J. P. (2023). Prostaglandin PGE2 Receptor EP4 Regulates Microglial Phagocytosis and Increases Susceptibility to Diet-Induced Obesity. Diabetes. https://doi.org/10.2337/db21-1072
Vancouver
Niraula A, Fasnacht RD, Ness KM, Frey JM, Cuschieri SA, Dorfman MD, et al. Prostaglandin PGE2 Receptor EP4 Regulates Microglial Phagocytosis and Increases Susceptibility to Diet-Induced Obesity. Diabetes. 2023. doi:10.2337/db21-1072
BibTeX
@article{Niraula2023,
author = {Niraula, Anzela and Fasnacht, Rachael D and Ness, Kelly M and Frey, Jeremy M and Cuschieri, Sophia A and Dorfman, Mauricio D and Thaler, Joshua P},
title = {Prostaglandin PGE2 Receptor EP4 Regulates Microglial Phagocytosis and Increases Susceptibility to Diet-Induced Obesity},
journal = {Diabetes},
year = {2023},
doi = {10.2337/db21-1072}
}
EUVIMED